Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Review of Meta-Analyses

被引：0
|
作者：
Bas P. L. Wijnhoven
Jan J. B. van Lanschot
Hugo W. Tilanus
Ewout W. Steyerberg
Ate van der Gaast
机构：
[1] Erasmus University Medical Center,Department of Surgery
[2] Erasmus University Medical Center,Department of Medical Oncology
[3] Erasmus University Medical Center,Department of Public Health
来源：
World Journal of Surgery | 2009年 / 33卷
关键词：
Esophageal Cancer; Complete Pathological Response; Primary Trial; Significant Survival Benefit; Advanced Esophageal Cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2606 / 2614
页数：8
相关论文
共 50 条
  • [41] Neoadjuvant chemoradiotherapy for operable esophageal cancer: Is paclitaxel necessary?
    Chino, J. P.
    Kelsey, C. R.
    Willett, C. G.
    Clough, R.
    Bendell, J. C.
    Hurwitz, H. I.
    D'Amico, T.
    Czito, B. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S292 - S293
  • [42] Is Neoadjuvant Chemoradiotherapy Safe for Elderly Patients with Esophageal Cancer?
    Wu, Geena X.
    Ituarte, Philip H. G.
    Chao, Joseph
    Chen, Yi-Jen
    Raz, Dan J.
    Trisal, Vijay
    Kim, Jae Y.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2015, 221 (04) : S150 - S151
  • [43] Neoadjuvant chemoradiotherapy for esophageal cancer - a single institution experience
    Ermenc, A. Secerov
    Anderluh, F.
    Peressutti, A. Jeromen
    Velenik, V.
    Oblak, I.
    Korosec, P.
    Hadzic, J. But
    Pulko, N.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1095 - S1095
  • [44] Present status and progress of neoadjuvant chemoradiotherapy for esophageal cancer
    Liu, Jing
    Yue, Jinbo
    Xing, Ligang
    Yu, Jinming
    FRONTIERS OF MEDICINE, 2013, 7 (02) : 172 - 179
  • [45] Is neoadjuvant chemoradiotherapy for pancreatic cancer beneficial: A systematic review and meta-analysis
    Luo, Wenhao
    Wang, Yawen
    Tao, Yinjie
    Zhang, Taiping
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [46] Recent meta-analyses in colorectal cancer
    Piedbois, P
    Buyse, M
    CURRENT OPINION IN ONCOLOGY, 2000, 12 (04) : 362 - 367
  • [47] Prolonged interval between neoadjuvant chemoradiotherapy and esophagectomy does not benefit the outcome in esophageal cancer: a systematic review and meta-analysis
    Tie, H.
    He, F.
    Shen, J.
    Zhang, B.
    Ye, M.
    Chen, B.
    Wu, Q.
    DISEASES OF THE ESOPHAGUS, 2018, 31 (01)
  • [48] Survival and complications after neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for esophageal squamous cell cancer: A meta-analysis
    Guo, Yaru
    Xu, Mingna
    Lou, Yufei
    Yuan, Yan
    Wu, Yuling
    Zhang, Longzhen
    Xin, Yong
    Zhou, Fengjuan
    PLOS ONE, 2022, 17 (08):
  • [49] Efficacy and safety of neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in locally advanced esophageal cancer: An updated meta-analysis
    Liang, Zhanpeng
    Chen, Ting
    Li, Wenxia
    Lai, Huiqin
    Li, Luzhen
    Wu, Jiaming
    Zhang, Huatang
    Fang, Cantu
    MEDICINE, 2024, 103 (03) : E36785
  • [50] Meta-analyses of brain cancer and farming
    Khuder, SA
    Mutgi, AB
    Schaub, EA
    AMERICAN JOURNAL OF INDUSTRIAL MEDICINE, 1998, 34 (03) : 252 - 260
12345